Medpage Today on MSN9mon
Defining and Diagnosing Chronic Inflammatory Demyelinating Polyneuropathy
Chronic inflammatory demyelinating polyneuropathy (CIDP) is the most common chronic immune-mediated neuropathy. It affects ...
Medpage Today on MSN9d
Patisiran Shows Long-Term Benefit in Hereditary ATTR With Polyneuropathy
Long-term treatment with patisiran (Onpattro) led to modest changes for people with hereditary transthyretin amyloidosis ...
Yahoo Finance17d
Polyneuropathy Treatment Market is Projected to Grow at a 4.9% CAGR, Reaching US$ 3.31 Billion by 2034 | Fact.MR Report
Rockville, MD , Jan. 07, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global Polyneuropathy Treatment Market is set to reach US$ 2.05 ...
pharmaphorum1y
FDA approves Ionis, AZ’s Wainua for ATTR polyneuropathy
AstraZeneca and Ionis are planning a US launch next month for Wainua, their treatment for polyneuropathy in life-threatening disease transthyretin-mediated amyloidosis (ATTR), after getting FDA ...
pharmaphorum6d
AZ, Ionis get CHMP backing for ATTR polyneuropathy drug
AstraZeneca and Ionis are set fair for EU approval of Wainzua, their treatment for polyneuropathy associated with transthyretin-mediated amyloidosis (ATTR), after the EMA's human medicines ...
Pharmabiz24d
argenx’s Vyvdura receives Japanese regulatory approval for adults with chronic inflammatory demyelinating polyneuropathy
Vyvgart Hytrulo is a prescription medicine used for the treatment of adult patients with chronic inflammatory demyelinating polyneuropathy (CIDP). The ADHERE trial was a multicenter, randomized, ...
Baylor College of Medicine4y
Chronic Inflammatory Demyelinating Polyneuropathy
Chronic inflammatory demyelinating polyneuropathy is an immune-mediated neuropathy that affects the peripheral motor and sensory nerves. The symptoms are of a slowly progressive numbness and tingling ...